Clever Leaves Holdings Common Stock Net 2019-2023 | CLVR

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Clever Leaves Holdings common stock net from 2019 to 2023. Common stock net can be defined as the value of common equity ownership.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Clever Leaves Holdings common stock net from 2019 to 2023. Common stock net can be defined as the value of common equity ownership.

Related Stocks
Company Name	Market Cap
Chugai Pharmaceutical (CHGCY)	$67.5B
Zoetis (ZTS)	$66B
Daiichi Sankyo, - (DSNKY)	$46.3B
Takeda Pharmaceutical (TAK)	$45.9B
BeOne Medicines - (ONC)	$31.8B
Sandoz Group AG (SDZNY)	$25.5B
Summit Therapeutics (SMMT)	$21B
Merck (MKKGY)	$16.3B
Shionogi (SGIOY)	$15.2B
United Therapeutics (UTHR)	$13.6B
Neurocrine Biosciences (NBIX)	$12.3B
Orion OYJ (ORINY)	$10.8B
IPSEN (IPSEY)	$10.4B
Madrigal Pharmaceuticals (MDGL)	$7.8B
Corcept Therapeutics (CORT)	$7.6B
Grifols, S.A (GRFS)	$7.3B
Stevanato Group S.p.A (STVN)	$6.6B
Ionis Pharmaceuticals (IONS)	$6.5B
Hikma Pharmaceuticals Plc (HKMPF)	$5.3B
Ono Pharmaceutical (OPHLF)	$5.1B
Soleno Therapeutics (SLNO)	$4.6B
AMNEAL PHARMACEUTICALS, INC (AMRX)	$2.8B
NewAmsterdam Pharma (NAMS)	$2.7B
Hypermarcas (HYPMY)	$2.7B
Crinetics Pharmaceuticals (CRNX)	$2.6B
Catalyst Pharmaceuticals (CPRX)	$2.4B
Centessa Pharmaceuticals (CNTA)	$2.2B
Ocular Therapeutix (OCUL)	$2.2B
Endo (NDOI)	$1.8B
BioCryst Pharmaceuticals (BCRX)	$1.7B